Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.

de Truchis P, Assoumou L, Landman R, Mathez D, Le Dû D, Bellet J, Amat K, Katlama C, Gras G, Bouchaud O, Duracinsky M, Abe E, Alvarez JC, Izopet J, Saillard J, Melchior JC, Leibowitch J, Costagliola D, Girard PM, Perronne C; ANRS 162-4D Study Group.

J Antimicrob Chemother. 2018 Mar 1;73(3):738-747. doi: 10.1093/jac/dkx434.

PMID:
29186458
2.

Four days a week or less on appropriate anti-HIV drug combinations provided long-term optimal maintenance in 94 patients: the ICCARRE project.

Leibowitch J, Mathez D, de Truchis P, Ledu D, Melchior JC, Carcelain G, Izopet J, Perronne C, David JR.

FASEB J. 2015 Jun;29(6):2223-34. doi: 10.1096/fj.14-260315. Epub 2015 Apr 1.

PMID:
25833895
3.

Plasma and Intracellular Antiretroviral Concentrations in HIV-Infected Patients under Short Cycles of Antiretroviral Therapy.

Zehnacker L, Abe E, Mathez D, Alvarez JC, Leibowitch J, Azoulay S.

AIDS Res Treat. 2014;2014:724958. doi: 10.1155/2014/724958. Epub 2014 Nov 9.

4.

The adult penile urethra is a novel entry site for HIV-1 that preferentially targets resident urethral macrophages.

Ganor Y, Zhou Z, Bodo J, Tudor D, Leibowitch J, Mathez D, Schmitt A, Vacher-Lavenu MC, Revol M, Bomsel M.

Mucosal Immunol. 2013 Jul;6(4):776-86. doi: 10.1038/mi.2012.116. Epub 2012 Nov 28.

PMID:
23187317
5.

Short cycles of antiretroviral drugs provide intermittent yet effective therapy: a pilot study in 48 patients with chronic HIV infection.

Leibowitch J, Mathez D, de Truchis P, Perronne C, Melchior JC.

FASEB J. 2010 Jun;24(6):1649-55. doi: 10.1096/fj.09-148676. Epub 2010 Jan 26.

PMID:
20103716
6.

Long-term control of viral residual replication under maintenance therapy with Trizivir after a quadruple induction regimen in HIV-1-infected adults (Suburbs trial).

de Truchis P, Mathez D, Force G, Rouveix E, Khuong MA, Chemlal K, Thiaux C, Leibowitch J.

HIV Clin Trials. 2007 Mar-Apr;8(2):102-4. No abstract available.

PMID:
17507326
7.

Is oxygen a key factor in the lipodystrophy phenotype?

Gentil C, Le Jan S, Philippe J, Leibowitch J, Sonigo P, Germain S, Piétri-Rouxel F.

Lipids Health Dis. 2006 Oct 18;5:27.

8.

Molecular detection of Cellulosimicrobium cellulans as the etiological agent of a chronic tongue ulcer in a human immunodeficiency virus-positive patient.

Heym B, Gehanno P, Friocourt V, Bougnoux ME, Le Moal M, Husson C, Leibowitch J, Nicolas-Chanoine MH.

J Clin Microbiol. 2005 Aug;43(8):4269-71.

9.

Oxygen consumption by cultured human cells is impaired by a nucleoside analogue cocktail that inhibits mitochondrial DNA synthesis.

Petit C, Piétri-Rouxel F, Lesne A, Leste-Lasserre T, Mathez D, Naviaux RK, Sonigo P, Bouillaud F, Leibowitch J.

Mitochondrion. 2005 Jun;5(3):154-61.

PMID:
16050981
10.

Quantitation of blood lymphocyte mitochondrial DNA for the monitoring of antiretroviral drug-induced mitochondrial DNA depletion.

Petit C, Mathez D, Barthélémy C, Leste-Lasserre T, Naviaux RK, Sonigo P, Leibowitch J.

J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):461-9.

PMID:
12869834
11.

Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection.

Brussel A, Mathez D, Broche-Pierre S, Lancar R, Calvez T, Sonigo P, Leibowitch J.

AIDS. 2003 Mar 28;17(5):645-52.

PMID:
12646786
12.

Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.

Levacher M, Bouscarat F, Landman R, Chau F, Damond F, Gaudebout C, Mathez D, Leibowitch J, Saimot AG, Sinet M.

AIDS Res Hum Retroviruses. 2000 Nov 20;16(17):1869-75.

PMID:
11118072
13.

[Antiretroviral therapy and immune reconstitution].

Carcelain G, Li TS, Renaud M, Blanc C, Tubiana R, Calvez V, Leibowitch J, Debré P, Agut H, Katlama C, Autran B.

J Soc Biol. 1999;193(1):5-10. Review. French.

PMID:
10851549
14.

T cell changes after combined nucleoside analogue therapy in HIV primary infection.

Carcelain G, Blanc C, Leibowitch J, Mariot P, Mathez D, Schneider V, Saimot AG, Damond F, Simon F, Debré P, Autran B, Girard PM.

AIDS. 1999 Jun 18;13(9):1077-81.

PMID:
10397538
15.

Restoration of the immune system with anti-retroviral therapy.

Autran B, Carcelaint G, Li TS, Gorochov G, Blanc C, Renaud M, Durali M, Mathez D, Calvez V, Leibowitch J, Katlama C, Debré P.

Immunol Lett. 1999 Mar;66(1-3):207-11. Review.

PMID:
10203056
16.

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debré P, Leibowitch J.

Science. 1997 Jul 4;277(5322):112-6.

17.

Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.

Mathez D, Bagnarelli P, Gorin I, Katlama C, Pialoux G, Saimot G, Tubiana P, De Truchis P, Chauvin JP, Mills R, Rode R, Clementi M, Leibowitch J.

Antivir Ther. 1997 Jul;2(3):175-83.

PMID:
11322272
18.

Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo.

Bagnarelli P, Valenza A, Menzo S, Sampaolesi R, Varaldo PE, Butini L, Montroni M, Perno CF, Aquaro S, Mathez D, Leibowitch J, Balotta C, Clementi M.

J Virol. 1996 Nov;70(11):7603-13.

19.

[Prolonged treatment with thalidomide in a patient with HIV infection].

Couderc LJ, Mathez D, Leibowitch J, Autran B, Caubarrere I.

Presse Med. 1995 Jan 7;24(1):40. French. No abstract available.

PMID:
7899338
20.
21.

The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.

Pedersen C, Cooper DA, Brun-Vézinet F, Doherty R, Skinhøj P, Pérol Y, Lüthy R, Leibowitch J, Habermehl KO, Varnier OE, et al.

AIDS. 1992 Aug;6(8):821-5.

PMID:
1418778
22.

Cystatin C levels in sera of patients with human immunodeficiency virus infection. A new avidin-biotin ELISA assay for its measurement.

Collé A, Tavera C, Prévot D, Leung-Tack J, Thomas Y, Manuel Y, Benveniste J, Leibowitch J.

J Immunoassay. 1992;13(1):47-60.

PMID:
1569212
23.

Productive human immunodeficiency virus infection levels correlate with AIDS-related manifestations in the patient.

Mathez D, Paul D, de Bélilovsky C, Sultan Y, Deleuze J, Gorin I, Saurin W, Decker R, Leibowitch J.

Proc Natl Acad Sci U S A. 1990 Oct;87(19):7438-42.

24.

Immunohistochemical evidence for human immunodeficiency virus-1 infection of liver Kupffer cells.

Housset C, Boucher O, Girard PM, Leibowitch J, Saimot AG, Bréchot C, Marche C.

Hum Pathol. 1990 Apr;21(4):404-8.

PMID:
2108080
25.

HIV expression levels ex vivo: a surrogate marker for clinical endpoints in the evaluation of AIDS treatments?

Mathez D, Paul D, Bélilovsky C, Sultan Y, Gorin I, Deleuze J, Saurin W, Decker R, Leibowitch J.

Dev Biol Stand. 1990;72:299-304. No abstract available.

PMID:
2282988
26.

Successful treatment of the pruritus of human immunodeficiency virus infection and acquired immunodeficiency syndrome with psoralens plus ultraviolet A therapy.

Gorin I, Lessana-Leibowitch M, Fortier P, Leibowitch J, Escande JP.

J Am Acad Dermatol. 1989 Mar;20(3):511-3. No abstract available.

PMID:
2918121
27.

HIV-2/LAV-2 in Portuguese man with AIDS (Paris, 1978) who had served in Angola in 1968-74.

Saimot AG, Coulaud JP, Mechali D, Matheron S, Dazza MC, Rey MA, Brun-Vezinet F, Leibowitch J.

Lancet. 1987 Mar 21;1(8534):688. No abstract available.

PMID:
2882109
28.

[Clinical and immunological abnormalities in heroin addicts with anti-HIV antibodies].

Ameille J, Cherin A, Conso F, Mathez D, Leibowitch J, Igou-Vacherot N, Nenna AD.

Ann Med Interne (Paris). 1987;138(5):386-7. French. No abstract available.

PMID:
3674619
29.

Needlestick HIV seroconversion in a nurse.

Neisson-Vernant C, Arfi S, Mathez D, Leibowitch J, Monplaisir N.

Lancet. 1986 Oct 4;2(8510):814. No abstract available.

PMID:
2876268
30.

Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III.

Piette AM, Tusseau F, Vignon D, Chapman A, Parrot G, Leibowitch J, Montagnier L.

Lancet. 1986 Apr 12;1(8485):852. No abstract available.

PMID:
2870330
31.

Lymphadenopathy-associated virus/human T-lymphotropic virus type III in allogeneic bone marrow transplantation.

Bierling P, Cordonnier C, Duedari N, Vernant JP, Leibowitch J, Mathez D.

Ann Intern Med. 1986 Jan;104(1):131-2. No abstract available.

PMID:
3000244
32.

Detection of infectious HTLV-III/LAV virus in cell-free plasma from AIDS patients.

Zagury D, Fouchard M, Vol JC, Cattan A, Leibowitch J, Feldman M, Sarin PS, Gallo RC.

Lancet. 1985 Aug 31;2(8453):505-6. No abstract available.

PMID:
2863528
33.

[Immune deficiency, sarcoidosis and primary biliary cirrhosis].

Bettan L, Belaiche J, Leibowitch J, Roucayrol AM, Even P, Kalifat R, Cattan D.

Gastroenterol Clin Biol. 1985 Aug-Sep;9(8-9):640-1. French. No abstract available.

PMID:
4076724
34.

HTLV-III in cells cultured from semen of two patients with AIDS.

Zagury D, Bernard J, Leibowitch J, Safai B, Groopman JE, Feldman M, Sarngadharan MG, Gallo RC.

Science. 1984 Oct 26;226(4673):449-51.

PMID:
6208607
35.

Antibodies to HTLV-III associated antigens in populations exposed to AIDS virus in France.

Mathez D, Leibowitch J, Matheron S, Saimot AG, Catalan P, Zaguri D.

Lancet. 1984 Aug 25;2(8400):460. No abstract available.

PMID:
6147522
36.

HTLV and AIDS in France.

Mathez D, Leibowitch J, Catalan P, Essex M, Zaguri D.

Lancet. 1984 Apr 7;1(8380):799. No abstract available.

PMID:
6143123
37.

[Pseudo-mycosis fungoides T-lymphoma associated with an HTLV retrovirus in an African].

Lessana-Leieowitch M, Leibowitch J, Frances C, Autran B, Gorin I, Escande JP.

Ann Dermatol Venereol. 1984;111(8):725-6. French. No abstract available.

PMID:
6099072
38.

Bronchoalveolar lavage in acquired immunodeficiency syndrome.

Venet A, Dennewald G, Sandron D, Stern M, Jaubert F, Leibowitch J.

Lancet. 1983 Jul 2;2(8340):53. No abstract available.

PMID:
6134921
39.

Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS).

Gallo RC, Sarin PS, Gelmann EP, Robert-Guroff M, Richardson E, Kalyanaraman VS, Mann D, Sidhu GD, Stahl RE, Zolla-Pazner S, Leibowitch J, Popovic M.

Science. 1983 May 20;220(4599):865-7.

PMID:
6601823
40.

Acquired immunodeficiency syndrome in France.

Brunet JB, Bouvet E, Leibowitch J, Chaperon J, Mayaud C, Gluckman JC, Picard O, Kernbaum S, Revuz J, Klatzmann D, Rosenbaum W, Lachiver D, Villalonga J, Wesselberg C.

Lancet. 1983 Mar 26;1(8326 Pt 1):700-1. No abstract available.

PMID:
6132052
41.

[Glomerulonephritis with intercapillary IgA deposits in benign monoclonal gammopathy].

Droz D, Noel LH, Barbanel C, Leibowitch J.

Nouv Presse Med. 1981 Dec 5;10(44):3652-3. French. No abstract available.

PMID:
7322898
42.

Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.

Gigli I, Sorvillo J, Mecarelli-Halbwachs L, Leibowitch J.

J Exp Med. 1981 Jul 1;154(1):1-12.

43.

[Immune complex nephropathy and hereditary deficiency of C1 esterase inhibitor (author's transl)].

Hory B, Panouse-Perrin J, Suzuki Y, Faivre R, Saint-Hillier Y, Coulon G, Leibowitch J.

Nouv Presse Med. 1981 Jun 13;10(26):2193-6. French.

PMID:
6455647
44.

Clq deposits at the dermoepidermal junction: a marker discriminating for discoid and systemic lupus erythematosus.

Leibowitch M, Droz D, Noël LH, Avril MF, Leibowitch J.

J Clin Immunol. 1981 Apr;1(2):119-24.

PMID:
7037828
45.

Systemic lambda light-chain deposition in a patient with myeloma.

Ganeval D, Noël LH, Droz D, Leibowitch J.

Br Med J (Clin Res Ed). 1981 Feb 28;282(6265):681-3.

46.

[Mixed nodular lymphoma in association with a C1 esterase inhibitor deficiency (author's transl)].

Leporrier M, Raphaël M, Delcourt A, Leibowitch J.

Nouv Rev Fr Hematol. 1981;23(4):243-8. French. No abstract available.

PMID:
7312618
47.

Tubular nephrotoxicity of water-soluble iodinated contrast media.

Moreau JF, Droz D, Noel LH, Leibowitch J, Jungers P, Michel JR.

Invest Radiol. 1980 Nov-Dec;15(6 Suppl):S54-60. No abstract available.

PMID:
7203949
48.

In vitro characteristics on human lymphocyte functions of a new immunomodulatory agent, a cyclic peptide, cyclomunine.

Niaudet P, Beaurain G, Leibowitch J, Bach JF.

Clin Exp Immunol. 1980 Nov;42(2):315-23.

49.

[Treatment of severe systemic lupus erythematosus. Long-term results in 55 patients (author's transl)].

Jungers P, Dougados M, Tron F, Lesavre P, Leibowitch J, Noël LH, Bach JF.

Nouv Presse Med. 1980 Sep 20;9(33):2329-37. French.

PMID:
7433023
50.

Supplemental Content

Loading ...
Support Center